Preview

Modern Rheumatology Journal

Advanced search

Role of immune inflammation in the pathogenesis of osteoarthrosis and possibilities of correction of immune impairments

https://doi.org/10.14412/1996-7012-2011-705

Abstract

A great role in the pathogenesis of osteoarthrosis has been recently assigned to immune impairments, particularly to the involvement of proinflammatory cytokines (interleukin 1 (IL-1), tumor necrosis factor-α (TNF-α)) that activate catabolic processes not only in cartilage tissue, but also in the subchodral bone and other articular structures. Non-steroidal anti-inflammatory drugs, symptomatic slow-acting agents (chondroitin and glucosamine sulfate), as well as diacerein that blocks IL-1 directly and TNF-α indirectly, reduce the activity of cytokines to some extent.

About the Author

R M Balabanova



References

1. <div><p>воспаление</p><p>нестероидные противовоспалительные препараты</p><p>диацереин</p><p>Van de Loo F.A., Joosten L.A., van Lent P.L. et al. Role of interleukin-1, tumor necrosis factor alpha, and inerleukin-6 in cartilage proteoglican metabolism and destruction: effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthr Rheum 1995;38:164-72.</p><p>Laporte J., Ibanez L., Vidal X. et al. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug safety 2004;27:411-20</p><p>Kulich W., Fagerer N., Schwann H. Effect of the NSAID nimesulide on the radical scavenger glutatione S-transferase in patients with osteoarthritis of the knee. Curr Med Res Opin 2007;23(8):1981-6</p><p>Helin-Salmivaara A., Virtanen A., Veslainen R. et al. NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a national case-control study from Finland. Eur Heart 2006;27:1657-63.</p><p>Traversa G., Bianchi C., Da Cas R. et al. Cohort study of hepatotoxity associated with nimesulide and other NSAIDs. Br Med J 2003;327:18-22.</p><p>Алексеева Л.И. Симптоматические препараты замедленного действия при лечении остеоартроза. Consilium medicum 2009;11:100-4.</p><p>McAlindon T.E., LaValley M.P., Gulin J.P. et al. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000;283:1469-75.</p><p>Коган К.М., Золотарева Г.Д., Бернштейн И.Л. и др. Практический опыт применения препаратов нимулид и кондронова окружными специалистами и врачами-ревматологами г. Москвы. Науч практич ревматол 2005;4:58-60.</p><p>Martel-Pelletier J., Mineau F., Jolicoeur F.C. et al. In vitro effects of Diacerhein and Rhein on IL-1 and TNF-α system in human osteoarthritis synovium and chondrocytes. J Rheumat 1998;25:753-62.</p><p>Pelletier J.P., Mineau F., Boileau C. et al. Diacerhein reduce the level of cartilage chondrocyte DNA fragmentation and death in experimental dog osteoarthritis cartilage at the same time that in inhibits caspase-3 and inducible nitric oxide synthase. Clin Exp Rheumat 2003;21:171-7.</p><p>Балабанова Р.М., Каптаева А.К. Артродарин - новый препарат патогенетической терапии остеоартроза. Науч практич ревматол 2009;2:49-53.</p><p>Зайцева Е.М., Алексеева Л.И. Причины боли при остеоартрозе и факторы прогрессирования заболевания. Науч практич ревматол 2011;1:50-7.</p><p>Pavelka K., Trc T., Karpas K. et al. The efficacy and safety of Diacerhein in the treatment of painful osteoarthritis of the knee : a randomised, multicentre, double-blind, placebo-controlled study with primery end points at two months after the end of a three-month treatment period. Arthr Rheum 2007;56:4055-64.</p><p>Rintelen B., Neumann K., Leeb B.F. A meta-analysis of controlled clinical studies with Diacerhein in the treatment osteoarthritis. Arch Intern Med 2006;166:1899-906.</p><p>Leeb B.F., Rintelen B. Systematic metaanalysis trials with Diacerhein in osteoarthritis.Osteoarth Cartilage 2005; 13(Suppl. A):S68. Dougades M., Nguen M., Berdah L. et al. Evaluation of the structure-modifying effects of Diacerhein in hip osteoarthritis. ECHODIAN, a three-etar placebo-controlled trial. Arthr Rheum 2001;44:2539-47.</p><p>Dougades M., Nguen M., Berdah L. et al. Evaluation of the structure-modifying effects of Diacerhein in hip osteoarthritis. ECHODIAN, a three-etar placebo-controlled trial. Arthr Rheum 2001;44:2539-47.</p></div><br />


Review

For citations:


Balabanova RM. Role of immune inflammation in the pathogenesis of osteoarthrosis and possibilities of correction of immune impairments. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2011;5(4):74-78. (In Russ.) https://doi.org/10.14412/1996-7012-2011-705

Views: 1122


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)